Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100
Closed -$9.6K 10290
2025
Q2
$9.6K Buy
+100
New +$9.71K ﹤0.01% 8881
2024
Q4
Sell
-300,000
Closed -$26.2M 9875
2024
Q3
$26.2M Buy
+300,000
New +$24M 0.01% 1615
2015
Q1
Sell
-500
Closed -$23K 8729
2014
Q4
$23K Buy
+500
New +$21.3K ﹤0.01% 7434

Other funds holding AEE

UBS Group's AEE Position: Q2 2026 in Review

UBS Group reduced its Ameren (AEE) stake by 14% in Q2 2026, selling an estimated $15.7M and leaving 875,191 shares worth $98.9M. The position accounts for 0.01% of the portfolio, ranked #1132.

UBS Group first reported a position in AEE in Q4 2014 and has held it in 47 quarters since. The position peaked at $149M in Q4 2024. 954 funds tracked by Wall St. Rank hold AEE as of Q2 2026.

  • UBS Group held 875,191 shares of Ameren worth $98.9M as of Q2 2026.
  • UBS Group sold 141,686 Ameren shares in Q2 2026, an estimated $15.7M.
  • Ameren made up 0.01% of UBS Group's portfolio in Q2 2026, its #1132 holding.
  • UBS Group first reported a position in Ameren in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Ameren position peaked at $149M in Q4 2024.
  • 954 funds tracked by Wall St. Rank held Ameren as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.